Streetbeat News

CLOV

Clover Health Investments, Corp.

https://www.cloverhealth.com

Industry

Medical - Healthcare Plans

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Open

3.65

Mkt cap

1.9B

Volume

3.3M

High

3.73

P/E Ratio

-40.89

52-wk high

4.87

Low

3.56

Div yield

N/A

52-wk low

0.61

Clover Health Investments is leveraging its AI capabilities to improve financial performance, with expected margin contraction in FY 2025 setting the stage for significant growth from FY 2026.

Portfolio Pulse from

March 07, 2025 | 1:00 pm

Hims & Hers Health Inc. recently saw its stock price reach an all-time high of nearly $73, but it quickly fell back to $36. The article suggests that Clover Health could be the next stock to watch.

Portfolio Pulse from

March 05, 2025 | 12:45 pm

Clover Health's Q4 2024 results show a mixed performance with earnings beating estimates but sales missing expectations. However, the company benefits from strong member retention and a positive revenue outlook.

Portfolio Pulse from

February 28, 2025 | 4:00 pm

Clover Health Investments, Corp. (CLOV) reported Q4 earnings of $0.02 per share, surpassing the Zacks Consensus Estimate of a $0.07 loss per share. This marks a significant improvement from the $0.12 loss per share reported a year ago.

Portfolio Pulse from

February 28, 2025 | 12:45 am

Clover Health Investments, Corp. (CLOV) held its Q4 2024 earnings call, discussing financial results and company performance. Key participants included CEO Andrew Toy and CFO Peter Kuipers.

Portfolio Pulse from

February 28, 2025 | 12:45 am

Clover Health reported improved financial results for 2024, with a significant reduction in net loss and increased adjusted EBITDA. The company is poised for growth in 2025, projecting a 30% increase in Medicare Advantage membership and substantial revenue growth.

Portfolio Pulse from

February 27, 2025 | 9:15 pm

Clover Health Investments, Corp. (Nasdaq: CLOV) announced its participation in the 2025 Jefferies Value-Based Healthcare Summit, with CFO Peter Kuipers representing the company.

Portfolio Pulse from

February 24, 2025 | 9:15 pm

Clover Health Investments, Corp. (Nasdaq: CLOV) will release its Q4 and full year 2024 financial results on February 27, 2025, after market close.

Portfolio Pulse from

February 18, 2025 | 9:30 pm

Clover Health has shown a 27% increase in Medicare Advantage members, surpassing 100,000, with 95% in its 4-Star PPO plan. Despite a 40% YTD rise, high retail ownership may lead to profit-taking post-Q4 earnings, similar to the Q3 selloff.

Portfolio Pulse from

February 11, 2025 | 4:00 pm

Clover Health Investments, Corp. is leveraging its proprietary AI technology to enhance its Medicare Advantage plans, creating a competitive advantage in the healthcare sector.

Portfolio Pulse from

January 21, 2025 | 9:00 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.